Do you want to read an article? Please log in or register.
Adjuvant chemotherapy in small node-negative triple-negative breast cancer
Breast Cancer
RECOMMENDED
Related content
Breast Cancer
Recent Developments in Metastatic Breast Cancer
healthbook TIMES Oncology Hematology
Breast Cancer
Addition of chemotherapy to local therapy in women aged 70 years or older with triple-negative breast cancer: a propensity-matched analysis
Lancet Oncol.
Crozier JA, Pezzi TA, Hodge C, Janeva S, Lesnikoski BA, Samiian L, Devereaux A, Hammond W, Audisio RA, Pezzi CM
doi: 10.1016/S1470-2045(20)30538-6.
Breast Cancer
Sequential vs concurrent epirubicin and docetaxel as adjuvant chemotherapy for high-risk, node-negative, early breast cancer: an interim analysis of a randomised phase III study from the Hellenic Oncology Research Group
Br J Cancer.
Mavroudis D, Saloustros E, Boukovinas I, Papakotoulas P, Kakolyris S, Ziras N, Christophylakis C, Kentepozidis N, Fountzilas G, Rigas G, Varthalitis I, Kalbakis K, Agelaki S, Hatzidaki D, Georgoulias V
doi: 10.1038/bjc.2017.158.
RECOMMENDED
Breast Cancer
Pembrolizumab for Early Triple-Negative Breast Cancer
★ 2
Recommended by
Prof. Dr Beat Thürlimann, Faculty Member
doi: 10.1056/NEJMoa1910549.
Breast Cancer
Association between Initiation of Adjuvant Chemotherapy Beyond 30 Days Following Surgery and Overall Survival Among Patients With Triple-Negative Breast Cancer
Int J Cancer.
Heeg E, Marang-van de Mheen PJ, Van Maaren MC, Schreuder K, Tollenaar RAEM, Siesling S, Bos MEMM, Vrancken Peeters MTFD
doi: 10.1002/ijc.32788.
RECOMMENDED
Breast Cancer
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)
doi: 10.1200/JCO.19.00904.
Breast Cancer
Race, ethnicity and clinical outcomes in hormone receptor-positive, HER2-negative, node-negative breast cancer in the randomized TAILORx trial
J Natl Cancer Inst.
Albain KS, Gray RJ, Makower DF, Faghih A, Hayes DF, Geyer CE, Dees EC, Goetz MP, Olson JA, Lively T, Badve SS, Saphner TJ, Wagner LI, Whelan TJ, Ellis MJ, Wood WC, Keane MM, Gomez HL, Reddy PS, Goggins TF, Mayer IA, Brufsky AM, Toppmeyer DL, Kaklamani VG, Berenberg JL, Abrams J, Sledge GW, Sparano JA
doi: 10.1093/jnci/djaa148.
Breast Cancer
Omitting radiation therapy in women with triple-negative breast cancer leads to worse breast cancer-specific survival
Breast.
Kindts I, Buelens P, Laenen A, Van Limbergen E, Janssen H, Wildiers H, Weltens C
doi: 10.1016/
Breast Cancer
Immunosuppressive profiles in liquid biopsy at diagnosis predict response to neoadjuvant chemotherapy in triple-negative breast cancer
Eur J Cancer.
Salvador-Coloma C, Santaballa A, Sanmartín E, Calvo D, García A, Hervás D, Cordón L, Quintas G, Ripoll F, Panadero J, Font de Mora J
doi: 10.1016/j.ejca.2020.08.020.